Garmaa G, Nagy R, Koi T, Do To U, Gergo D, Kleiner D
BMC Nephrol. 2024; 25(1):261.
PMID: 39138396
PMC: 11323638.
DOI: 10.1186/s12882-024-03702-y.
Mahtal N, Lenoir O, Tinel C, Anglicheau D, Tharaux P
Nat Rev Nephrol. 2022; 18(10):643-662.
PMID: 35974169
DOI: 10.1038/s41581-022-00608-6.
Golonka R, Cooper J, Issa R, Devarasetty P, Gokula V, Busken J
Curr Hypertens Rep. 2021; 23(5):28.
PMID: 33961141
PMC: 8105193.
DOI: 10.1007/s11906-021-01142-9.
Lu L, Kingdom J, Burton G, Cindrova-Davies T
Am J Pathol. 2017; 187(4):908-920.
PMID: 28157488
PMC: 5397715.
DOI: 10.1016/j.ajpath.2016.12.002.
Chakraborty C, Chin K, Das S
Tumour Biol. 2016; 37(10):13039-13048.
PMID: 27468722
DOI: 10.1007/s13277-016-5156-1.
Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases.
Bhatt K, Kato M, Natarajan R
Am J Physiol Renal Physiol. 2015; 310(2):F109-18.
PMID: 26538441
PMC: 4719041.
DOI: 10.1152/ajprenal.00387.2015.
Triptolide Attenuates Podocyte Injury by Regulating Expression of miRNA-344b-3p and miRNA-30b-3p in Rats with Adriamycin-Induced Nephropathy.
Jiang C, Wei M, Tu Y, Zhu H, Li C, Jing W
Evid Based Complement Alternat Med. 2015; 2015:107814.
PMID: 26078766
PMC: 4452866.
DOI: 10.1155/2015/107814.
Mechanisms and therapeutic potential of microRNAs in hypertension.
Shi L, Liao J, Liu B, Zeng F, Zhang L
Drug Discov Today. 2015; 20(10):1188-204.
PMID: 26004493
PMC: 4609581.
DOI: 10.1016/j.drudis.2015.05.007.
The regulation and function of microRNAs in kidney diseases.
Wei Q, Mi Q, Dong Z
IUBMB Life. 2013; 65(7):602-14.
PMID: 23794512
PMC: 3694742.
DOI: 10.1002/iub.1174.
Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator.
Cindrova-Davies T, Herrera E, Niu Y, Kingdom J, Giussani D, Burton G
Am J Pathol. 2013; 182(4):1448-58.
PMID: 23410520
PMC: 3608014.
DOI: 10.1016/j.ajpath.2013.01.001.
MicroRNAs as newer therapeutic targets: A big hope from a tiny player.
Ghelani H, Rachchh M, Gokani R
J Pharmacol Pharmacother. 2012; 3(3):217-27.
PMID: 23129956
PMC: 3487269.
DOI: 10.4103/0976-500X.99416.
MicroRNAs in hypertension: mechanisms and therapeutic targets.
Batkai S, Thum T
Curr Hypertens Rep. 2011; 14(1):79-87.
PMID: 22052337
DOI: 10.1007/s11906-011-0235-6.
Cardiac insulin resistance and microRNA modulators.
Pulakat L, Aroor A, Gul R, Sowers J
Exp Diabetes Res. 2011; 2012:654904.
PMID: 21977024
PMC: 3184440.
DOI: 10.1155/2012/654904.
Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension.
Wang X, Prins B, Sober S, Laan M, Snieder H
Curr Hypertens Rep. 2011; 13(6):442-51.
PMID: 21953487
PMC: 3212682.
DOI: 10.1007/s11906-011-0230-y.
Detecting microRNA activity from gene expression data.
Madden S, Carpenter S, Jeffery I, Bjorkbacka H, Fitzgerald K, ONeill L
BMC Bioinformatics. 2010; 11:257.
PMID: 20482775
PMC: 2885376.
DOI: 10.1186/1471-2105-11-257.
Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes.
Liu Y, Taylor N, Lu L, Usa K, Cowley Jr A, Ferreri N
Hypertension. 2010; 55(4):974-82.
PMID: 20194304
PMC: 2862728.
DOI: 10.1161/HYPERTENSIONAHA.109.144428.
MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression.
Sober S, Laan M, Annilo T
Biochem Biophys Res Commun. 2009; 391(1):727-32.
PMID: 19944075
PMC: 2806518.
DOI: 10.1016/j.bbrc.2009.11.128.
The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1.
Agrawal R, Tran U, Wessely O
Development. 2009; 136(23):3927-36.
PMID: 19906860
PMC: 2778741.
DOI: 10.1242/dev.037432.
MicroRNA: a new frontier in kidney and blood pressure research.
Liang M, Liu Y, Mladinov D, Cowley Jr A, Trivedi H, Fang Y
Am J Physiol Renal Physiol. 2009; 297(3):F553-8.
PMID: 19339633
PMC: 2739705.
DOI: 10.1152/ajprenal.00045.2009.
Individual mRNA expression profiles reveal the effects of specific microRNAs.
Arora A, Simpson D
Genome Biol. 2008; 9(5):R82.
PMID: 18485210
PMC: 2441468.
DOI: 10.1186/gb-2008-9-5-r82.